{
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": [
        "Financial Derivative Instruments (FDIs) for non-replication purposes",
        "Specialized healthcare technology index complexity"
    ],
    "classification": "complex",
    "supporting_data": "The ETF primarily uses physical replication but explicitly mentions the use of 'financial derivative instruments (FDIs)' for purposes beyond simple replication, including investing in companies with similar risk/performance characteristics to the index constituents. This introduces complexity as it involves derivative usage that goes beyond standard efficient portfolio management. Additionally, the specialized nature of the ROBO Global Healthcare Technology and Innovation Index, which involves complex scoring methodologies and focuses on niche healthcare technology sub-sectors, adds another layer of complexity that may not be easily understood by retail investors.",
    "confidence": 85,
    "counter_argument": "The ETF could be argued as non-complex due to its primary use of physical replication and straightforward accumulation structure. However, the explicit mention of derivative usage for non-replication purposes and the complexity of the underlying index outweigh this argument, as MiFID II considers both the investment strategy and the understandability of the underlying assets."
}